CIK 0001553643 · Non-accelerated filer<br>Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 455401931
- Phone
- 646 876 3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- Open-market buys, last 90 days
- $1,671,990
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,671,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-08 | Shenouda Maged CFO | Option exercise | +10,000 | $3.24 | $32K | 12,228 |
| 2021-03-08 | Shenouda Maged CFO | Sale | −100 | $35.00 | $4K | 12,128 |
| 2021-03-08 | Shenouda Maged CFO | Option exercise · Options to purchase common stock | −10,000 | 70,350 | ||
| 2021-03-01 | CASAMENTO CHARLES J Director | Sale | −3,000 | $33.87 | $102K | 15,950 |
| 2021-02-24 | TRAVERSA SERGIO CEO | Option exercise | +10,000 | $3.24 | $32K | 98,774 |
| 2021-02-24 | TRAVERSA SERGIO CEO | Sale | −4,837 | $33.69 | $163K | 93,937 |
| 2021-02-24 | TRAVERSA SERGIO CEO | Sale | −4,860 | $34.70 | $169K | 89,077 |
| 2021-02-24 | TRAVERSA SERGIO CEO | Sale | −303 | $35.55 | $11K | 88,774 |
| 2021-02-24 | TRAVERSA SERGIO CEO | Option exercise · Options to purchase common stock | −10,000 | 109,211 | ||
| 2021-02-24 | Kelly Paul Edward Director | Option exercise | +5,000 | $3.24 | $16K | 172,295 |
| 2021-02-24 | Kelly Paul Edward Director | Sale | −2,429 | $33.67 | $82K | 169,866 |
| 2021-02-24 | Kelly Paul Edward Director | Sale | −2,463 | $34.64 | $85K | 167,403 |
| 2021-02-24 | Kelly Paul Edward Director | Sale | −108 | $35.58 | $4K | 167,295 |
| 2021-02-24 | Shenouda Maged CFO | Option exercise | +3,000 | $3.24 | $10K | 5,228 |
| 2021-02-24 | Shenouda Maged CFO | Sale | −1,600 | $33.74 | $54K | 3,628 |
| 2021-02-24 | Shenouda Maged CFO | Sale | −1,400 | $34.67 | $49K | 2,228 |
| 2021-02-24 | Shenouda Maged CFO | Option exercise · Options to purchase common stock | −3,000 | 80,250 | ||
| 2021-02-08 | Kelly Paul Edward Director | Option exercise · Options to purchase common stock | −5,000 | 55,500 |
Page 9 of 9 · 178 trades